BACKGROUND: Increased carotid artery intima-media thickness (IMT) is a noninvasive marker of systemic arterial disease, associated with atherosclerosis, abnormal arterial mechanics, myocardial infarction, and stroke. In the elderly, clinically elevated IMT is related to diminished attention-executive function. In this context, previous work involving paper-and-pencil measures of cognition has demonstrated that a threshold of pathology (i.e., IMT>or=0.9 mm) is needed before IMT consistently relates to poor neuropsychological test performance. Given the critical role of arterial health in the development of cognitive dysfunction, the goal of this study was to investigate early markers of brain vulnerability by examining subclinical levels of IMT in relation to a sensitive marker of neuronal integrity, cerebral N-acetyl-aspartate/creatine (NAA/Cr) ratio, in midlife. METHODS: A total of 40 participants aged 50+/-6 years, underwent neuropsychological assessment, proton magnetic resonance spectroscopy ((1)H MRS) examination of occipitoparietal grey matter and B-mode ultrasound of the common carotid artery. IMT was defined as the distance between the luminal-endothelial interface and the junction between the media and the adventitia. The relation between IMT and cerebral metabolite ratios was modeled using a single multivariate multiple regression analysis adjusted for age and current systolic blood pressure. RESULTS: Increased IMT was associated with significantly lower NAA/Cr ratios (IMT beta=-0.62, p=0.001), independent of age and systolic blood pressure (F(3,36)=4.928, p=0.006). CONCLUSIONS: Our study extends previous findings by demonstrating a significant relationship between IMT and NAA concentration, suggesting compromised neuronal viability even at IMT levels below thresholds for clinical end-organ damage. Copyright (c) 2010 Elsevier B.V. All rights reserved.
BACKGROUND: Increased carotid artery intima-media thickness (IMT) is a noninvasive marker of systemic arterial disease, associated with atherosclerosis, abnormal arterial mechanics, myocardial infarction, and stroke. In the elderly, clinically elevated IMT is related to diminished attention-executive function. In this context, previous work involving paper-and-pencil measures of cognition has demonstrated that a threshold of pathology (i.e., IMT>or=0.9 mm) is needed before IMT consistently relates to poor neuropsychological test performance. Given the critical role of arterial health in the development of cognitive dysfunction, the goal of this study was to investigate early markers of brain vulnerability by examining subclinical levels of IMT in relation to a sensitive marker of neuronal integrity, cerebral N-acetyl-aspartate/creatine (NAA/Cr) ratio, in midlife. METHODS: A total of 40 participants aged 50+/-6 years, underwent neuropsychological assessment, proton magnetic resonance spectroscopy ((1)H MRS) examination of occipitoparietal grey matter and B-mode ultrasound of the common carotid artery. IMT was defined as the distance between the luminal-endothelial interface and the junction between the media and the adventitia. The relation between IMT and cerebral metabolite ratios was modeled using a single multivariate multiple regression analysis adjusted for age and current systolic blood pressure. RESULTS: Increased IMT was associated with significantly lower NAA/Cr ratios (IMT beta=-0.62, p=0.001), independent of age and systolic blood pressure (F(3,36)=4.928, p=0.006). CONCLUSIONS: Our study extends previous findings by demonstrating a significant relationship between IMT and NAA concentration, suggesting compromised neuronal viability even at IMT levels below thresholds for clinical end-organ damage. Copyright (c) 2010 Elsevier B.V. All rights reserved.
Authors: Andreana P Haley; Daniel E Forman; Athena Poppas; Karin F Hoth; John Gunstad; Angela L Jefferson; Robert H Paul; Albert S H Ler; Lawrence H Sweet; Ronald A Cohen Journal: Int J Cardiol Date: 2006-12-28 Impact factor: 4.164
Authors: K Kantarci; C R Jack; Y C Xu; N G Campeau; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E Kokmen; E G Tangalos; R C Petersen Journal: Neurology Date: 2000-07-25 Impact factor: 9.910
Authors: P Talelli; J Ellul; G Terzis; N P Lekka; G Gioldasis; A Chrysanthopoulou; Th Papapetropoulos Journal: J Neurol Sci Date: 2004-08-30 Impact factor: 3.181
Authors: J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark Journal: Neurology Date: 1989-09 Impact factor: 9.910
Authors: Wenjun Zhong; Karen J Cruickshanks; Guan-Hua Huang; Barbara E K Klein; Ronald Klein; F Javier Nieto; James S Pankow; Carla R Schubert Journal: Atherosclerosis Date: 2011-07-20 Impact factor: 5.162
Authors: Carla R Schubert; Karen J Cruickshanks; Mary E Fischer; A Alex Pinto; Yanjun Chen; Guan-Hua Huang; Barbara E K Klein; Ronald Klein; James S Pankow; Adam J Paulsen; Dayna S Dalton; Ted S Tweed Journal: J Gerontol A Biol Sci Med Sci Date: 2019-10-04 Impact factor: 6.053
Authors: Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Lana L Watkins; Benson M Hoffman; Andrew Sherwood Journal: Am J Geriatr Psychiatry Date: 2018-06-28 Impact factor: 4.105
Authors: Carla R Schubert; Karen J Cruickshanks; Mary E Fischer; Guan-Hua Huang; Ronald Klein; Michael Y Tsai; A Alex Pinto Journal: J Gerontol A Biol Sci Med Sci Date: 2014-09-02 Impact factor: 6.053
Authors: Wenjun Zhong; Karen J Cruickshanks; Carla R Schubert; Charles W Acher; Cynthia M Carlsson; Barbara E K Klein; Ronald Klein; Richard J Chappell Journal: Atherosclerosis Date: 2012-07-25 Impact factor: 5.162